Compounds > 5-(tetradecyloxy)-2-furancarboxylic acid
Page last updated: 2024-09-03

5-(tetradecyloxy)-2-furancarboxylic acid and Benign Neoplasms

5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abramson, HN1
Cao, D; Liao, DF; Luo, D; Sun, M; Wang, C; Xu, C1

Other Studies

2 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Benign Neoplasms

ArticleYear
The lipogenesis pathway as a cancer target.
    Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16

    Topics: Acetyl-CoA Carboxylase; Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Biosynthetic Pathways; Fatty Acid Synthases; Fatty Acids; Humans; Lipogenesis; Models, Chemical; Molecular Structure; Neoplasms

2011
Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis.
    Biochemical and biophysical research communications, 2009, Jul-31, Volume: 385, Issue:3

    Topics: Acetyl-CoA Carboxylase; Apoptosis; Cytotoxins; Enzyme Inhibitors; Furans; Humans; Neoplasms; Palmitic Acid

2009